Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2848 (LINC02848) is a type of long intergenic non-coding RNA (lincRNA) that does not code for proteins and is transcribed from regions of the genome that do not overlap with protein-coding genes[1][5]. Its specific biological function has not been characterized, and it is not presently considered a therapeutic target. LincRNAs, as a class, are involved in diverse regulatory roles in gene expression at multiple levels (transcriptional and posttranscriptional) and can act in cis or trans to regulate neighboring or distant genes, respectively[7][9]. Specific disease relevance, interacting drugs, mechanisms of action, or use as a biomarker for LINC02848 has not been reported in the available scientific literature[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2848 (LINC02848).